Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $129.7B | - | $1.2B | $375M | 6.7% | 10.1% | -1.6% |
| 2024 | $117.8B | - | $1.2B | $2.4B | 7.4% | 10.7% | -51.5% |
| 2023 | $106.4B | - | $2.5B | $3.0B | 15.3% | 14.5% | -11.3% |
| 2022 | $92.9B | - | $2.8B | $3.5B | 18.3% | - | - |
| 2021 | - | - | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total Revenue | - | 92,870 | 106,374 | 117,761 | 129,664 |
| Operating Revenue | - | 92,870 | 106,374 | 117,761 | 129,664 |
| Total Expenses | - | 89,302 | 102,991 | 116,040 | 128,109 |
| EBIT | - | 3,969 | 3,876 | 2,381 | 2,186 |
| Interest Expense | - | 401 | 493 | 660 | 631 |
| Net Interest Income | - | -401 | -493 | -660 | -631 |
| Interest Expense Non Operating | - | 401 | 493 | 660 | 631 |
| Net Non Operating Interest Income Expense | - | -401 | -493 | -660 | -631 |
| Pretax Income | - | 3,568 | 3,383 | 1,721 | 1,555 |
| Tax Provision | - | 762 | 836 | 413 | 250 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | 50.61 | 0 | 0 | -11.66 |
| Net Income Continuous Operations | - | 2,802 | 2,484 | 1,214 | 1,203 |
| Net Income From Continuing And Discontinued Operation | - | 2,806 | 2,489 | 1,207 | 1,188 |
| Net Income From Continuing Operation Net Minority Interest | - | 2,806 | 2,489 | 1,207 | 1,188 |
| Net Income | - | 2,806 | 2,489 | 1,207 | 1,188 |
| Net Income Common Stockholders | - | 2,806 | 2,489 | 1,207 | 1,188 |
| Net Income Including Noncontrolling Interests | - | 2,802 | 2,484 | 1,214 | 1,203 |
| Normalized Income | - | 2,619.61 | 2,489 | 1,207 | 1,243.34 |
| Diluted NI Availto Com Stockholders | - | 2,806 | 2,489 | 1,207 | 1,188 |
| Basic Average Shares | - | 126.42 | 123.87 | 120.57 | 120.45 |
| Diluted Average Shares | - | 127.09 | 124.44 | 120.87 | 120.83 |
| Reconciled Depreciation | - | 845 | 917 | 968 | 824 |
| Total Unusual Items | - | 237 | 0 | 0 | -67 |
| Total Unusual Items Excluding Goodwill | - | 237 | 0 | 0 | -67 |
| Minority Interests | - | 4 | 5 | -7 | -15 |
| Earnings From Equity Interest Net Of Tax | - | -4 | -63 | -94 | -102 |
| Special Income Charges | - | 237 | 0 | 0 | -67 |
| Other Special Charges | - | -237 | - | - | 67 |
| Depreciation And Amortization In Income Statement | - | 709 | 779 | 839 | 698 |
| Other Operating Expenses | - | 12,739 | 13,325 | 13,877 | 15,901 |
| Loss Adjustment Expense | - | 75,690 | 88,394 | 100,664 | 110,812 |
| Net Policyholder Benefits And Claims | - | 75,690 | 88,394 | 100,664 | 110,812 |
Healthcare sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| Humana Inc.this co. | HUM | $42.0B | 35.35 | 2.38 | 6.7% | - |
| Edwards Lifesciences Corporation | EW | $50.4B | 46.91 | 4.87 | 10.4% | 33.19 |
| Cardinal Health, Inc. | CAH | $47.2B | 30.27 | -16.99 | -56.1% | 16.71 |
| IDEXX Laboratories, Inc. | IDXX | $44.5B | 42.05 | 27.75 | 66.0% | 30.06 |
| Becton, Dickinson and Company | BDX | $41.2B | 24.56 |
| - |
| - |
| - |
| - |
| 1.62 |
| 6.6% |
| 12.06 |
| Alnylam Pharmaceuticals, Inc. | ALNY | $40.5B | 129.21 | 51.37 | 39.8% | 61.62 |
| Agilent Technologies, Inc. | A | $39.1B | 29.99 | 5.80 | 19.3% | 22.15 |
| Waters Corporation | WAT | $37.0B | 57.52 | 14.43 | 25.1% | 36.74 |
| Zoetis Inc. | ZTS | $33.3B | 12.47 | 10.01 | 80.2% | 9.90 |
| Peer Median | - | 36.16 | 7.90 | 22.2% | 26.11 | |